Vivesto Stock

Vivesto Current Ratio

The Current Ratio of Vivesto (VIVE.ST) as of Aug 10, 2026 is 3.51. In the previous year, Current Ratio was 5.95 — a change of -41.00% (lower).

Current Ratio

3.51

YoY

-41.00%

Last updated:

Current Ratio of Vivesto is 2026 3.51 . Current Ratio of Vivesto was 2025 5.95 . It decreases by -41.00% lower compared to the previous year.
Access this data via the Eulerpool API

Vivesto Stock analysis

What does Vivesto do? Oasmia Pharmaceutical AB is a Swedish pharmaceutical company that specializes in the development and marketing of innovative cancer and pain medications. The company was founded in 1998 and is headquartered in Uppsala, Sweden. Vivesto is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vivesto stock

Current Ratio of Vivesto is 3.51 in 2026.

Current Ratio of Vivesto changed from 5.95 to 3.51, representing a -41.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Ratio Vivesto since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's Vivesto with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Vivesto

All Key Metrics — Vivesto